Phase 3 Study of Yimitasvir Phosphate Capsules

Clinical trial NCT03487107 · COMPLETED

Trial details

NCT number: NCT03487107
Sponsor: Sunshine Lake Pharma Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic HCV Infection

Start date: 2018-04-17
Primary completion: 2019-03-28
Enrollment: 362

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.